论文部分内容阅读
本文测定了15例 IDDM 患者治疗前后血清可溶白细胞介素—2受体(sIL—2R)水平.结果发现 IDDM 患者治疗前(sIL—2R)水平显著升高,治疗后 sIL—2R 恢复至正常范围。结果提示:IDDM 患者体内存在细胞因子免疫调节紊乱,sIL—2R 可反映疾病的免疫动态.
This study measured the serum soluble interleukin-2 receptor (sIL-2R) levels in 15 IDDM patients before and after treatment, and found that the level of sIL-2R was significantly elevated in IDDM patients before treatment, and sIL-2R returned to normal after treatment range. The results suggest that there is disorder of immune regulation of cytokines in IDDM patients, and sIL-2R can reflect the immune dynamics of disease.